EMA COVID-19 guidance: research and development

The European Medicines Agency (EMA) provides support to medicine developers researching and developing potential COVID-19 medicines. Dedicated guidance, rapid procedures and contact points are available.

EMA: COVID-19 guidance: research and development

Table of contents

• Contact for early support
• Rapid procedures
• Clinical trials for COVID-19 medicines (updated)
• COVID-19-related observational studies
• Standards and requirements on pharmaceutical quality
• Paediatric development plans: joint submission to EMA and FDA

Interested in learning more? Contact us today to find out how we can help with your global regulatory needs.